Prophylactic aspirin therapy of at least 5 years’ duration has a favorable benefit-harm profile, primarily because of its effectiveness in preventing colorectal and other cancers, according to a...
Prophylactic aspirin therapy of at least 5 years’ duration has a favorable benefit-harm profile, primarily because of its effectiveness in preventing colorectal and other cancers, according to a...
Three to four years of therapy with the bisphosphonates alendronate and zoledronic acid, taken at doses used to treat osteoporosis, did not decrease the risk of incident breast cancer in...
Three to four years of therapy with the bisphosphonates alendronate and zoledronic acid, taken at doses used to treat osteoporosis, did not decrease the risk of incident breast cancer in...
Women who recently used oral contraceptives had a 50% greater chance of developing breast cancer than that of women who formerly used or never used oral contraceptives, according to a case-control...
Women who recently used oral contraceptives had a 50% greater chance of developing breast cancer than that of women who formerly used or never used oral contraceptives, according to a case-control...
Among patients with resectable esophageal adenocarcinoma, tumor stage after completion of neoadjuvant chemotherapy is a much more important predictor of survival than is initial tumor stage at...
Among patients with resectable esophageal adenocarcinoma, tumor stage after completion of neoadjuvant chemotherapy is a much more important predictor of survival than is initial tumor stage at...
The encouraging results of a small study of women with ductal carcinoma in situ comparing oral tamoxifen to a gel formulation of a tamoxifen metabolite support further testing of local transdermal...
The encouraging results of a small study of women with ductal carcinoma in situ comparing oral tamoxifen to a gel formulation of a tamoxifen metabolite support further testing of local transdermal...